Volume 31, Issue 3, Pages (September 2009)

Slides:



Advertisements
Similar presentations
Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.
Advertisements

Dendritic Cells: Tissue-specific
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll  Cancer Cell 
Experimental Models of Inflammatory Bowel Diseases
Gut-Busters: IL-17 Ain’t Afraid of No IL-23
Volume 31, Issue 3, Pages (September 2009)
Barrier Epithelial Cells and the Control of Type 2 Immunity
Bridget A. Robinson, Timothy J. Nice  Immunity 
Cancer Immunotherapy by Dendritic Cells
Bugs and Brain: How Infection Makes You Feel Blue
The Leptin Connection: Regulatory T Cells and Autoimmunity
cIAP Proteins: Keystones in NOD Receptor Signal Transduction
Microbial Influences in Inflammatory Bowel Diseases
Nader Yatim, Matthew L. Albert  Immunity 
Toll-like Receptors Keep Antigen Sorting on the Right Track
Eos, Goddess of Treg Cell Reprogramming
2008: A MyD88 O, DC  Bali Pulendran, Weiping Cao  Immunity 
Some DCs Are “B”etter Immunity
Nicholas van Bruggen, Wenjun Ouyang  Immunity 
Volume 37, Issue 2, Pages (August 2012)
T Helper 17 Cells Get the NOD
Checks and Balances: IL-23 in the Intestine
Metastasis-Promoting Immunity: When T Cells Turn to the Dark Side
Never Underestimate the Power of a Neutrophil
Pathogen Recognition and Innate Immunity
Warren Strober, Ivan J. Fuss  Gastroenterology 
Arming Treg Cells at the Inflammatory Site
Lung Homeostasis: Influence of Age, Microbes, and the Immune System
Mucosal Immunology of Food Allergy
BTLA+ Dendritic Cells: The Regulatory T Cell Force Awakens
Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
Innate Immunity: Ignored for Decades, but Not Forgotten
Turning Tumors into Vaccines: Co-opting the Innate Immune System
The Role of Retinoic Acid in Tolerance and Immunity
Yasmine Belkaid, Guillaume Oldenhove  Immunity 
Natural Killer Cell Memory
Volume 135, Issue 5, Pages e5 (November 2008)
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Taia T. Wang, Jeffrey V. Ravetch  Immunity 
The Fire Within: Microbes Inflame Tumors
Taro Kawai, Shizuo Akira  Immunity  Volume 34, Issue 5, Pages (May 2011)
Innate Lymphoid Cells in Inflammation and Immunity
Homeostasis and Inflammation in the Intestine
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
APRIL in the Intestine: A Good Destination for Immunoglobulin A2
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Revisiting the role of B cells in skin immune surveillance
DC-SIGN: The Strange Case of Dr. Jekyll and Mr. Hyde
Volume 30, Issue 2, Pages (February 2009)
Inflammation NODs to Antagonists of RIP2-XIAP Interaction
Regulatory B Cells: Origin, Phenotype, and Function
Cytokine Signaling Modules in Inflammatory Responses
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
NODding off in acute kidney injury with progranulin?
Regulatory T Cells in Asthma
Peripheral Tolerance of CD8 T Lymphocytes
Intracellular NOD-like Receptors in Host Defense and Disease
The Biology of Intestinal Immunoglobulin A Responses
Learning Tolerance while Fighting Ignorance
Releasing the Brakes on Cancer Immunotherapy
Some DCs Are “B”etter Immunity
TAMpering with Toll-like Receptor Signaling
cGAS Dimerization Entangles DNA Recognition
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
The Regulatory T Cell Transcriptosome: E Pluribus Unum
Volume 25, Issue 3, Pages (September 2006)
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
Presentation transcript:

Volume 31, Issue 3, Pages 377-388 (September 2009) The Multifaceted Influence of the Mucosal Microflora on Mucosal Dendritic Cell Responses  Warren Strober  Immunity  Volume 31, Issue 3, Pages 377-388 (September 2009) DOI: 10.1016/j.immuni.2009.09.001 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Effector and Regulatory Dendritic Cells Antigen-sampling dendritic cells mediate induction of effector T cells. CX3CR1+ DCs (and/or DCs bearing other chemokine receptors) extend processes (dendrites) between epithelial cells and into the gut lumen to sample antigens associated with micro-organisms above the epithelial layer. These cells then present antigen to CD4+ T cells that then become effector T cells producing proinflammatory cytokines. Thus, antigen-sampling DCs serve host-defense functions. DCs not involved in antigen sampling serve as inducers of regulatory T cells. CD103+ DCs, probably after “conditioning” by epithelial cells, present antigens to naive T cells in the context of retinoic acid (RA) and TGF-β secretion. Antigens presented in this case access the dendritic cell by antigen entry process not involving dendrite sampling. Immunity 2009 31, 377-388DOI: (10.1016/j.immuni.2009.09.001) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Foxp3− Regulatory Cells Induced by Gut Microflora Components Administration of ethanol or V. cholera zona occludens toxin causes a transient decrease in epithelial barrier function and increased exposure to gut microflora components. This, in turn, leads to induction of Foxp3−, LAP+ (latency-associated protein-positive) regulatory T cells. CD11c+ DCs in the lamina propria induce Foxp3−, LAP+ regulatory T cells upon sensing a TLR2 ligand. Subsequent attempts to induce TNBS-colitis in these mice or in mice that are adoptively transferred with lamina propria cells from these mice are thwarted by the presence of the regulatory T cells. Immunity 2009 31, 377-388DOI: (10.1016/j.immuni.2009.09.001) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Two Phases of NOD2 Function Initial (proinflammatory) phase. NOD2 recognition of ligand (muramyl dipeptide [MDP]) results in oligomerization and conformational changes that allow interaction between the CARD domain and RICK (RIP2). This is followed by ubiquitination of RICK and activation of TAK1 and NF-kB. Ubiquitinated Rick also leads to concomitant TLR signaling. Persistent (anti-inflammatory) phase. NOD2 activation leads to induction of IRF4 synthesis and subsequent formation of RICK-IRF4 complex, which inhibits TLR signaling. Thus, administration of MDP to mice inhibits experimental colitis. Immunity 2009 31, 377-388DOI: (10.1016/j.immuni.2009.09.001) Copyright © 2009 Elsevier Inc. Terms and Conditions